InterCare DX, Inc.
InterCare DX, Inc. (ICCO) Free Cash Flow & Analysis
Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.
ICCO · free cash flow · updated Jun 15, 2026
Core FCF metrics
ICCO · FCF · TTM · margin & CAGRFree cash flow was −$789 for FY2022 (fiscal year ending 2022-12-31), down 22.3% year-over-year
Annual free cash flow history
Annual free cash flow data
FCF valuation metrics
ICCO · P/FCF · FCF yield · FCF per shareInterCare DX, Inc. (ICCO) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.
FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.
Cash flow statement summary
ICCO · cash flow statement · operating / investing / financingFor FY2022, InterCare DX, Inc. generated −$0.0M in operating cash flow and spent 0M in capital expenditures, yielding −$0.0M in free cash flow.
For the complete Operating / Investing / Financing line-item breakdown:
View Full Cash Flow Statement →Free cash flow vs peers (Healthcare)
About Free Cash Flow & Methodology
InterCare DX, Inc. (ICCO) reported free cash flow of −$789 for FY2022 (fiscal year ending 2022-12-31), down 22.3% year-over-year.
InterCare DX, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 3 fiscal years.
Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.
Frequently asked questions
ICCO free cash flow · 8 questionsInterCare DX, Inc. free cash flow was −$789 for FY2022, down 22.3% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$808.674.
▸ Source: FMP /cash-flow-statement · US GAAP · InterCare DX, Inc. · InterCare DX, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026